Impact
A bigger and stronger platform
Prior-edition figures sourced from post-show reporting for 2026; confirm against organiser press release when available. The 2026 edition brought together 250+ visitors at 27.
Event overview
Overview
The Women's Health & Cancer Conference will be held in Paris, France, on April 27-28, 2027. This summit aims to advance women's health through prevention, early detection, and inclusive care.
It will gather healthcare professionals, researchers, and advocates to discuss critical developments in women's health and cancer awareness. Women's Health & Cancer Conference takes place in Paris, FR.
TL;DR
- 1Dates and Venue: The Women's Health & Cancer Conference takes place on April 27-28, 2027, in Paris, France.
- 2Scale and Focus: This international summit focuses on advancing women's health through prevention and early detection.
- 3Organiser: The event is organized by Conference Series LLC, known for hosting global health conferences.
- 4Buyer Authority: Attendees include healthcare professionals, researchers, and patient advocates with significant influence in women's health.
- 5Entry: Registration is open now; visit the official website for details.
Why visit
Attendees will gain insights into the latest advancements in women's health and cancer care, participate in networking opportunities, and engage with leading experts in the field. Attendees include healthcare professionals, researchers, and patient advocates with significant influence in women's health.
Why exhibit
Exhibitors will have the chance to showcase their products and services to a targeted audience of healthcare professionals and decision-makers. This is an excellent opportunity to network, generate leads, and enhance visibility in the women's health sector. Meet qualified buyers and partners including Pharmaceutical companies, Medical device manufacturers, Healthcare technology developers. Position your offer across cancer screening technologies, women's health.
Attendees, exhibitors & solutions
Who this event is for
Visitor profile
Typical attendee groups you can expect to meet.
Medical oncologists treating breast, ovarian, cervical, endometrial and other gynaecologic cancers
Gynaecologic oncologists and breast surgeons reviewing surgical and systemic therapy pathways
Radiation oncologists planning adjuvant and metastatic treatment protocols
Clinical researchers and principal investigators running women's cancer trials
Molecular pathologists and genomic scientists working on HRD, HER2-low and BRCA testing
Radiologists and imaging specialists in breast screening and staging
Oncology nurses, nurse navigators and advanced practice providers
Patient advocacy leaders and survivorship programme managers
Health economists, HTA analysts and market access specialists in oncology
Pharmaceutical and diagnostics medical affairs professionals tracking pipeline data
Public health officials and screening programme managers
Fellows, residents and PhD students building a women's cancer specialisation
Exhibitor profile
Main supplier and exhibitor segments present at the show.
Pharmaceutical companies with breast, ovarian and gynaecologic cancer portfolios
Biotech developers of antibody-drug conjugates, PARP inhibitors and checkpoint inhibitors
Companion diagnostics and genomic testing laboratories (BRCA, HRD, ctDNA)
Contract research organisations and site networks recruiting for women's cancer trials
Imaging and screening equipment suppliers for mammography and ultrasound
Digital health vendors for tumour boards, ePRO and survivorship follow-up
Patient support, fertility preservation and advocacy organisations
Medical publishers, oncology societies and continuing education providers
Cold-chain logistics, biospecimen transport and central lab services
Market access consultancies and real-world evidence providers
Product categories
Key solution areas showcased across the event.
Breast cancer therapeutics, including antibody-drug conjugates and endocrine therapy
Gynaecologic oncology agents for ovarian, cervical and endometrial cancer
Companion diagnostics and germline/somatic genomic testing
Liquid biopsy and circulating tumour DNA monitoring platforms
Mammography, tomosynthesis, ultrasound and MRI screening systems
Pathology workflows, digital pathology and biomarker scoring tools
Clinical trial services, site management and patient recruitment platforms
ePRO, survivorship and patient navigation software
Fertility preservation and supportive care products
Real-world evidence, registry and outcomes research services
Location & Facilities
Venue
27
Paris, FR
Facilities
Parking
27 in Paris typically provides on-site or adjacent visitor parking during major trade fairs; confirm daily rates, payment methods and hall access on the organiser or venue website before travel.
Food options
On-site catering
On-site diningParking: 27 in Paris typically provides on-site or adjacent visitor parking during major trade fairs; confirm daily rates, payment methods and hall access on the organiser or venue website before travel.
Gate: Follow organiser signage to the main visitor entrance at 27 for badge collection; allow extra time for security screening during peak morning arrival.
Attend
Entry & tickets
How the last edition performed
Previous edition
Last edition
2026
reported
Visitors: 250
Next edition
Not announced yet
Intelligence
Market context
Key market insights, trends, news and related events to help you understand the bigger picture.
Paris, FR
Why it matters
On 2027-04-27 to 2027-04-28, Women's Health & Cancer Conference in Paris covering Cancer screening technologies, Women's health pharmaceuticals, Diagnostic imaging equipment, Healthcare IT solutions, Pa gives medical buyers a single calendar window to compare suppliers, validate specs on the stand, and book follow-ups before the next buying cycle - especially when your roadmap matches the published exhibitor profile.
Industry trends
Key trends shaping this market and its wider industry.
Digital buyer journeys
What digital buyer journeys means for buyers and exhibitors in this sector.
Sustainability in procurement
What sustainability in procurement means for buyers and exhibitors in this sector.
Automation and labour efficiency
What automation and labour efficiency means for buyers and exhibitors in this sector.
Regional supply-chain resilience
What regional supply-chain resilience means for buyers and exhibitors in this sector.
Hybrid engagement models
What hybrid engagement models means for buyers and exhibitors in this sector.
Plan your trip
Travel & logistics
Local currency · EUR
Arrival airports
Choose from the following airports, with convenient access to the event and venue.
Charles de Gaulle
Charles de Gaulle (CDG) is the main commercial gateway serving Paris; allow 45-60 min by road or rail to 27
to venue
by car
Paris Orly
Paris Orly (ORY) is the main commercial gateway serving Paris; allow 45-60 min by road or rail to 27
to venue
by car
Paris Beauvais
Paris Beauvais (BVA) is the main commercial gateway serving Paris; allow 45-60 min by road or rail to 27
to venue
by car
Hotel tiers
A range of accommodation options near the venue and across key areas.
Hôtel Du Lys
3-star
ParisUSD 95–122 / night
Hôtel Atrium by HappyCulture
3-star
ParisUSD 95–122 / night
Mont Dore Hotel - Paris Batignolles
3-star
Paris BatignollesUSD 95–122 / night
Les Tournelles
3-star
ParisUSD 95–122 / night
Hôtel Libertel Canal Saint-Martin
3-star
Paris Canal Saint-MartinUSD 95–122 / night
Villa Beaumarchais
4-star
ParisUSD 150–190 / night
Novotel Paris Est
4-star
Paris EstUSD 150–190 / night
Local transport
Get around the city with these convenient transport options.
RER / metro
Estimated costCost TBA
Best forCharles de Gaulle (CDG) to 27
Paris Aéroport lists public transport options from CDG into Paris; check RER and connecting metro routes for the venue district.
metro / RER
Estimated costCost TBA
Best forParis Orly (ORY) to 27
Rome2rio lists train and line 14 subway options between Paris and Orly; verify current fares and connections.
shuttle bus
Estimated costCost TBA
Best forParis Beauvais (BVA) to 27
Aéroport Paris-Beauvais operates an official Paris airport shuttle; check the operator timetable for departure points and pricing.
metro / bus / tram
Estimated costCost TBA
Best forCentral Paris to 27 venue district
RATP operates metro, RER, tram and bus across Ile-de-France; use the RATP route planner to reach the venue from your hotel.
Weather
April 2027
Plan for the climate
Check temperatures and pack accordingly
Venue connectivity
Confirm mobile roaming or local SIM options for business visitors to FR.
Ride-hailing
Taxis
Public transit
Car rentals
Cultural notes
Useful information to help you have a smooth and respectful visit.
Registration
Confirm registration and venue access with the organiser before travelling to Paris.
Arrival
Arrive early on the first show day for orientation and security screening.
Practical guides
Visitor & Exhibitor Essentials
Everything needed to arrive prepared, navigate the event, and make the visit productive.
Flights
Destination: CDG
Google Flights returns CDG as the destination for all sampled origins; round-trip searches for 2027-04-27 to 2027-05-01 show London prices below usual and Tokyo prices above usual. Fares include taxes and fees for one adult but exclude optional bag fees, and live prices should be confirmed at booking.
Transport
Get to the venue and around the city with these options.
Airport → venue: Primary gateways: Charles de Gaulle (CDG): Charles de Gaulle (CDG) is the main commercial gateway serving Paris; allow 45-60 min by road or rail to 27; Paris Orly (ORY): Paris Orly (ORY) is the main commercial gateway serving Paris; allow 45-60 min by road or rail to 27; Paris Beauvais (BVA): Paris Beauvais (BVA) is the main commercial gateway serving Paris; allow 45-60 min by road or rail to 27. Allow road or rail time to 27; on-site parking is usually available at major exhibition venues.
Hotel → venue: Precinct hotels near 27: Paris: Hôtel Du Lys; Paris: Hôtel Atrium by HappyCulture; Paris Batignolles: Mont Dore Hotel - Paris Batignolles.
Ride-hail: Ride-hailing apps are commonly used in Paris; confirm local availability before travel.
Public transit: Paris is served by RATP metro, RER, tram and bus networks plus Transilien regional trains. For airport arrivals, Paris Aéroport documents CDG and ORY public transport connections; Beauvais is linked by an official shuttle bus. Use the RATP route planner (bonjour-ratp.fr) for real-time schedules, and confirm current fares before travel.
Parking: On-site parking is available at 27; confirm daily rates and hall access on the organiser or venue site.
Weather
Plan and pack for the event climate.
Month: April 2027
Packing: April 2027
Plan your trip
Planning
Best day to visit: Day 2 (mid-show)
Mid-show days at Women's Health & Cancer Conference usually combine full exhibitor attendance with scheduled B2B meetings, before early pack-down on the final day.
Day 1
T-14 days: book or reconfirm a refundable hotel near a metro or RER line that reaches the venue district in under 30 minutes
Day 2
T-12 days: map your daily route from hotel to venue and note a backup metro or bus line in case of disruption on the RATP network
Day 3
T-10 days: check your passport validity (Schengen guidance: valid at least three months beyond departure) and, if needed, confirm your Schengen visa is issued
Day 4
T-10 days: download the RATP and Ile-de-France Mobilites apps and load a Navigo Easy or phone-based ticket option
Day 5
T-7 days: review the published programme and shortlist sessions on screening, biomarker testing, trial design and survivorship
Day 6
T-7 days: request any patient-advocacy or trainee rate documentation before the organiser's deadlines; T-5 days: set up a meeting schedule with sponsors and diagnostics providers whose pipeline matters to your practice
Day 7
T-3 days: print or save offline copies of badge confirmation, hotel voucher and insurance details
Day 8
T-2 days: check the Paris forecast and pack a waterproof layer, business casual layers and comfortable shoes
Day 9
T-1 day: arrive early enough to absorb any RER or metro disruption and collect your badge before the opening session
Day 10
carry a charged phone with the venue address saved, plus a physical card for metro ticket machines that may not accept foreign apps
Day 11
T-14 days: confirm your registration confirmation, badge collection instructions and photo ID requirement with the organiser
Sample visitor itinerary
Route-optimised day
Day 1 · morning
Registration and hall orientation at 27
Day 2 · core sessions
Supplier meetings and product demos
Day 3 · wrap-up
Final negotiations and follow-up
Networking spots
2Women's Health & Cancer Conference registration concourse
27
Central meeting point before and between hall appointments during show days.
Organiser B2B lounge (if offered)
27
Hosted matchmaking and buyer programmes when published by the organiser.
Budget
Costs & budget
Build your working budget
Adjust the inputs below to create a directional event budget.
Estimated budget
Live estimate
- Hotel × 2 nights€190.00
- Per diem × 2€150.00
Estimated total€340.00
This is a directional estimate. Please verify live rates before booking.
Decision
Visit, exhibit, or skip?
Should you go?
Use this quick check to decide whether Women's Health & Cancer Conference fits your visit, exhibit or skip plan.
QUESTION 1 OF 6
For Women's Health & Cancer Conference, what is your primary role on the show floor?
Decision matrix
Compare participation options side by side to choose the best fit for your objectives.
visit
Your category focus and target suppliers align with the official exhibitor profile.
Best for
Buyers, engineers, and delegates sourcing Cancer screening technologies and Women's health pharmaceuticals solutions and benchmarking suppliers at Women's Health & Cancer Conference in Paris.
Min. budget
$491.00
Timeline
4-8 weeks before opening day for registration, hotels, and travel.
Risks
Session times and ticket tiers may change - confirm the official agenda before booking.
exhibit
You have a defined lead-generation or distributor recruitment goal for this market.
Best for
Brands and manufacturers launching Cancer screening technologies and Women's health pharmaceuticals products who need qualified meetings with the event's trade audience.
Min. budget
$2,209.00
Timeline
3-6 months for stand booking, freight, staffing, and pre-show marketing.
Risks
Booth pricing and corner premiums vary by hall - confirm with the organiser sales team.
skip
Audience, geography, or commercial goals do not justify travel and stand costs this cycle.
Best for
Teams with weak category fit, budget constraints, or overlapping commitments during the Paris show week.
Timeline
N/A
Risks
Skipping may mean missing buyer meetings if competitors exhibit or attend the same week.
FAQs & glossary
Answers
Frequently asked
When and where does the 2027 Women's Health Cancer Summit take place?
The 2027 edition is listed for 27-28 April 2027 in Paris, France. The summit runs across two days; confirm the exact venue address and hall on the organiser site before booking travel and hotels.
Who is the summit designed for?
The programme is aimed at clinicians and researchers working in women's cancers: medical, gynaecologic, surgical and radiation oncologists, pathologists, oncology nurses, clinical trial teams, patient advocacy groups and the pharmaceutical, diagnostics and digital health companies that supply them.
How do I register and what does the pass include?
Registration is handled through the organiser domain. Pass categories, group rates and any member or trainee discounts are published there, and confirm whether your pass covers both days, catering and any associated workshop before you book flights.
Is the event open to trade visitors only or also to patients and the public?
It is a professional clinical and industry meeting rather than a public patient event. If you are attending as a patient advocate or representative of a patient organisation, check with the organiser which registration route applies to you.
Are continuing medical education (CME) credits available?
Accreditation status is set by the organiser and any accrediting body each year. Check the programme or registration page for the current CME/CPD statement rather than assuming credits from a previous edition.
Can I submit an abstract or propose a session?
Abstract and session calls, when offered, are announced on the organiser site with a fixed submission window and formatting rules. There is no evidence of an open call in the current listing, so confirm dates directly with the organisers before preparing a submission.
What language is the summit delivered in?
Sessions are expected to be delivered in English for an international clinical audience. Confirm with the organiser if you need interpretation or accessibility support.
Which airport should I fly into for a Paris summit?
Paris-Charles de Gaulle (CDG) has the widest long-haul choice and a direct RER B rail link into central Paris. Paris-Orly (ORY) is closer to the south of the city and connects by metro line 14 and the Orlyval shuttle, while Paris-Beauvais (BVA) is a secondary airport served by an official coach to Porte Maillot.
Do I need a visa to attend in France?
EU/EEA and many other passport holders can enter France visa-free for short stays, while other nationalities need a Schengen short-stay visa applied for in advance at a French consulate. Requirements vary by passport, so verify with the French consulate in your country before paying for travel.
What is the weather like in Paris in late April?
Late April is spring in Paris, with typical daytime highs near 15-17 C, cool nights around 6-9 C and a realistic chance of showers. Pack a light waterproof layer and comfortable shoes for metro and walking between hotels and the venue.
How early should I book hotels and flights?
Paris in spring fills up with congress and leisure demand. Book a refundable hotel near a metro or RER interchange roughly two to three months ahead, and lock flights once the venue and daily programme timings are confirmed.
Glossary
- Gynaecologic oncology
- The subspecialty of cancer medicine covering ovarian, fallopian tube, peritoneal, uterine, cervical, vulvar and vaginal cancers, combining surgery, chemotherapy and radiotherapy.
- Triple-negative breast cancer (TNBC)
- Breast cancer lacking oestrogen receptor, progesterone receptor and HER2 amplification, which limits endocrine and HER2-directed options and drives chemotherapy and immunotherapy research.
- HER2-low
- A breast cancer category with low-level HER2 expression that is not classically HER2-positive but can respond to HER2-directed antibody-drug conjugates.
- HRD (homologous recombination deficiency)
- A DNA repair defect in tumours, common in high-grade serous ovarian cancer, used to select patients for PARP inhibitor therapy.
- PARP inhibitor
- A drug class that blocks poly-ADP ribose polymerase repair of DNA damage, exploited in BRCA-mutated and HRD-positive tumours.
- Liquid biopsy
- Testing blood or other fluids for circulating tumour DNA or cells to detect, genotype or monitor cancer without a tissue biopsy.
- ctDNA
- Circulating tumour DNA shed by tumours into the bloodstream, used for minimal residual disease detection and resistance monitoring.
- Companion diagnostic (CDx)
- A test validated to guide a specific therapy decision, such as BRCA testing before PARP inhibitor use or PD-L1 scoring before immunotherapy.
- Molecular tumour board
- A multidisciplinary review meeting where pathologists, oncologists and genomic scientists agree on actionable alterations and matched therapies.
- Real-world evidence (RWE)
- Clinical insight generated from routine care data such as registries and electronic records, used alongside trials for access and outcomes claims.
- Health technology assessment (HTA)
- Formal appraisal of a treatment's clinical and economic value by a payer body, which determines reimbursement in many European markets.
- Survivorship care plan
- A structured follow-up plan covering recurrence surveillance, late treatment effects, fertility and psychosocial support after primary treatment.
1
2
3
4
5
6
7
8
9
10
11
12
Also known as
Alternate names and search phrases for this event.
- Women's Health & Cancer Conference 2027
- Women's Health & Cancer Conference Paris 2027
- Women 2027
- Women Paris 2027
- Health 2027
- Health Paris 2027
- Paris FR
- Cancer screening technologies
- Women's health pharmaceuticals
Trust footer
Sources
1
References
1
Publishers
0
Date checked
1
Conference Series LLC
- event_website
Digital business cards for the show floor
Display a free company card at your booth, or share your professional card on the show floor.